Stocks will continue to broaden beyond the mega-caps in 2026 – Charles Schwab’s Liz Ann Sonders
Seeking Alpha News (Tue, 16-Dec 2:35 PM ET)
PRNewswire (Thu, 11-Dec 7:38 AM ET)
NUTEX HEALTH EXTENDS SHARE REPURCHASE PLAN
PRNewswire (Thu, 4-Dec 5:30 AM ET)
NUTEX HEALTH RESPONDS TO SHORT SELLER REPORT
PRNewswire (Wed, 26-Nov 4:10 PM ET)
NUTEX HEALTH REOPENS RED RIVER ER & HOSPITAL IN TEXAS
PRNewswire (Mon, 24-Nov 4:39 PM ET)
NUTEX HEALTH REPORTS SEPTEMBER 30, 2025 THIRD QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS
PRNewswire (Wed, 19-Nov 4:30 PM ET)
NUTEX HEALTH REPORTS JUNE 30, 2025 SECOND QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS
PRNewswire (Tue, 18-Nov 6:59 PM ET)
NUTEX HEALTH REPORTS RESTATED FIRST QUARTER 2025 FINANCIAL RESULTS
PRNewswire (Tue, 18-Nov 6:50 PM ET)
NUTEX HEALTH REPORTS RESTATED 2024 FINANCIAL RESULTS
PRNewswire (Tue, 18-Nov 6:27 PM ET)
Globe Newswire (Thu, 23-Oct 6:35 PM ET)
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
Nutex Health trades on the NASDAQ stock market under the symbol NUTX.
As of December 19, 2025, NUTX stock price climbed to $171.93 with 178,493 million shares trading.
NUTX has a beta of 1.18, meaning it tends to be more sensitive to market movements. NUTX has a correlation of 0.03 to the broad based SPY ETF.
NUTX has a market cap of $1.22 billion. This is considered a Small Cap stock.
Last quarter Nutex Health reported $268 million in Revenue and $7.76 earnings per share. This beat revenue expectation by $54 million and exceeded earnings estimates by $5.81.
In the last 3 years, NUTX traded as high as $324.00 and as low as $4.16.
The top ETF exchange traded funds that NUTX belongs to (by Net Assets): AVUV, IWM, VTI, IWO, CALF.
NUTX has outperformed the market in the last year with a price return of +484.8% while the SPY ETF gained +18.1%. NUTX has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +78.9% and +6.8%, respectively, while the SPY returned +2.8% and -0.5%, respectively.
NUTX support price is $153.94 and resistance is $179.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NUTX shares will trade within this expected range on the day.
